+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat



Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat



Naunyn-Schmiedeberg's Archives of Pharmacology 330(1): 42-49



Comparative pharmacokinetic studies with the beta-receptor blocking drugs propranolol, metoprolol, sotalol and atenolol, differing greatly in lipophilicity, and their main route of elimination were performed in light-dark-synchronized rats after equimolar single (6 mumoles/kg) or multiple (6 X 6 mumoles/kg) drug application. Drug concentrations were determined in plasma and various target organs of the drugs, e.g. heart, muscle, lung and brain, after drug application in the light period (L) and dark period (D), respectively. After single drug administration pharmacokinetic parameters of all drugs depended on the L and D conditions. Elimination half-lives in plasma and organs were shorter during D than during L. No L-D-differences were found in initial drug concentrations of the hydrophilic drugs sotalol and atenolol. In contrast, C0-values of the lipophilic propranolol in highly perfused organs (muscle, lung, brain) and of metoprolol in muscle tissue were significantly higher in D than in L. No obvious temporal dependency was found in other pharmacokinetic parameters (AUC, plasma clearance, Vd beta) with the exception in Vd beta of propranolol. Due to the different physico-chemical properties of the compounds inter-drug-differences in pharmacokinetic parameters including drug accumulation into lung and brain tissue were observed. Multiple drug dosing abolished the circadian-phase-dependency in the elimination half-lives of the drugs due to an increase in D. Only for the highly lipophilic propranolol half-lives in highly perfused organs were still shorter in D than in L.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039552781

Download citation: RISBibTeXText

PMID: 2864639

DOI: 10.1007/bf00586708


Related references

The ocular penetration of beta adrenoceptor blocking drugs a comparative study on atenolol sotalol pindolol metoprolol timolol and propranolol. Greve, E L (Ed ) Documenta Ophthalmologica Proceedings Series, Vol 22 Glaucoma Symposium: Diagnosis And Therapy; Amsterdam, Netherlands, Sept 1979 Xv+419p Dr W Junk Bv Publishers: The Hague, Netherlands (Dist in The Usa By Kluwer Boston, Inc , Hingham, Mass ) Illus P313-326, 1980

Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity. Arzneimittel-Forschung 35(10): 1580-1582, 1985

Enantioselective bioanalysis of beta-blocking agents: focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol. Biomedical Chromatography 7(6): 277-295, 1993

Pharmaco kinetics of beta adrenoceptor blocking drugs of different polarity propranolol metoprolol atenolol in plasma and various organs of the light dark synchronized rat. Naunyn-Schmiedeberg's Archives of Pharmacology 316(SUPPL): R60, 1981

Interindividual variation of beta adrenoceptor blocking drugs plasma concentration and effect influence of genetic status on behavior of atenolol bopindolol and metoprolol. European Journal of Clinical Pharmacology 28(2): 149-154, 1985

Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol. Documenta Ophthalmologica. Advances in Ophthalmology 48(2): 291-301, 1980

Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog. Pharmacology 28(3): 121-129, 1984

Synthesis of the carbon 11 labelled beta adrenergic receptor ligands atenolol metoprolol and propranolol. Applied Radiation & Isotopes 40(7): 561-564, 1989

Beta adrenergic blocking drugs propranolol and sotalol effects on myo cardial contractility and hemodynamics. Federation Proceedings 29(2): 476, 1970

Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography. Journal of Chromatography 382: 215-224, 1986

Beta-receptor blocking effect in human by propranolol and metoprolol. Zhonghua Xin Xue Guan Bing Za Zhi 18(4): 226-228, 1990

Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers. British Journal of Clinical Pharmacology 19 Suppl 2: 197s-201s, 1985

Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol. Australian and New Zealand Journal of Medicine 11(1): 35-40, 1981

A study on the beta receptor blocking effect in human by propranolol and metoprolol. Zhonghua Xinxueguanbing Zazhi 18(4): 226-228, 1990

The beta 1- and beta 2-adrenoceptor affinity of atenolol and metoprolol. A receptor-binding study performed with different radioligands in tissues from the rat, the guinea pig and man. Biochemical Pharmacology 37(2): 203-208, 1988